6
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Human Corticotropin-Releasing Hormone Improves Overnight FEV1 in Nocturnal Asthma

, , &
Pages 261-265 | Published online: 02 Jul 2009

References

  • Vale W, Spiess J, Rivier C, et al. Characterization of 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and P-endorphin. Science 1981; 213: 1394–1397
  • Dunn A J, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res Rev 1990; 15: 71–100
  • Kiang J G, Poree L, Wei ET. Anti-inflammatory activity of corticotropin-releasing factor. II. Mechanisms of action. Proc Western Pharmacol Soc 1987; 30: 63–65
  • Gao G C, Dashwood M R, Wei ET. Corticotropin-releasing factor inhibition of substance P-induced vascular leakage in rats: possible sites of action. Peptides 1991; 12: 639–644
  • Wei E T, Gao GC. Corticotropin-releasing factor: An inhibitor of vascular leakage in skeletal muscle and brain cortex after injury. Regul Peptides 1991; 33: 93–104
  • Serda S M, Wei ET. Epinephrine-induced pulmonary edema in rats is inhibited by corticotropin-releasing factor. Pharmacol Res 1992; 26: 85–91
  • Wei E T, Kiang JG. Inhibition of protein exudation from the trachea by corticotropin-releasing factor. Eur J Pharm 1987; 140: 63–67
  • Serda S M, Wei ET. Epinephrine-induced pulmonary edema in rats is inhibited by corticotropin-releasing factor. Pharm Res 1992; 26: 85–91
  • Tjuvajev J, Uehara H, Desai R, et al. Anti-edematous efficacy of corticotropin releasing factor. Comparison with dexamethasone for treatment of peritumoral brain edema (abstract). J Cereb Blood Flow Metab 1995; 15: S171
  • Barnes P J, Chung K F, Page CP. Inflammatory mediators and asthma. Pharmacol Rev 1988; 40: 49–84
  • Chung K F, Rogers D F, Barnes P J, et al. The role of increased airway microvascular permeability and-plasma exudation in asthma. Eur Respir J 1990; 3: 329–337
  • Wilhem DL. The mediation of increased vascular permeability in inflammation. Pharmacol Rev 1962; 14: 251–280
  • Nink M, Krause U, Lehnert H, et al. Safety and side effects of human and ovine corticotropin-releasing hormone administration in man. Klin Wochenscrift 1991; 69: 185–195
  • Medical Section of the American Lung Association: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225–245
  • Snedecor G W, Cochran WG. Statistical Methods8th ed. Iowa State University Press, Ames, IA 1989; 177–178; 193–194

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.